Skip to main content

Head and Neck Cancer International Group (HNCIG)

CGH Program/Initiative Type: Cancer Research and Research Networks Support

The Head and Neck Cancer International Group was established in 2014 with the mission to promote and conduct high quality head and neck cancer clinical trials worldwide to improve outcomes in patients diagnosed with these diseases. This is achieved through international collaboration, a strong sense of common purpose, shared expertise, and mutual respect among members.

The primary goals of the HNCIG are to:

  • Promote definitive international clinical trials in H&N cancer
  • Perform studies in rare H&N tumors
  • Harmonize the technical aspects of radiation delivery
  • Develop a credentialing process for novel radiation or surgical approaches
  • Promote translational research
  • Support educational activities

Member organizations of the HNCIG include groups with experience collaborating to conduct late phase interventional trials and meta-analyses in head and neck cancers, including: Canadian Cancer Trials Group,Cancer Trials Ireland, Danish Head and Neck Cancer Group (DAHANCA), ECOG-ACRIN, European Organisation for the Research and Treatment of Cancer (EORTC), Fudan University, Gruppo Oncologico del Nord Ovest (GONO), Groupe d’Oncologie Radiothérapie Tête Et Cou (GORTEC), Hellenic Cooperative Oncology Group (HeCOG), Hong Kong Nasopharyngeal Carcinoma Study Group, Interdisziplinäre Arbeitsgruppe Kopf-Hals-Tumoren der Deutschen Krebsgesellschaft (IAG KHT), Japan Clinical Oncology Group (JCOG), MACH-NC Collaborative Group (Meta-Analyses of Chemotherapy in Head and Neck Cancer, Institut Gustav Roussy), National Cancer Research Infrastructure, UK (NCRI),National Cancer Centre, Singapore, NRG Oncology, Nederlandse Werkgroep Hoofd-Hals Tumoren (NWHHT), Tata Memorial Centre, Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC), Taiwan Cooperative Oncology Group (TCOG), and the Trans Tasman Radiation Oncology Group (TROG).

For more information on this initiative, please contact the Center for Global Health at